Credit Suisse’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-116,532
| Closed | -$6.07M | – | 3547 |
|
|
2017
Q3 | $6.07M | Hold |
116,532
| – | – | 0.01% | 1328 |
|
|
2017
Q2 | $6.03M | Buy |
116,532
+29,283
| +34% | +$1.51M | 0.01% | 1271 |
|
|
2017
Q1 | $4.39M | Buy |
87,249
+81,381
| +1,387% | +$4.09M | ﹤0.01% | 1496 |
|
|
2016
Q4 | $277K | Sell |
5,868
-89,997
| -94% | -$4.25M | ﹤0.01% | 3334 |
|
|
2016
Q3 | $4.78M | Buy |
95,865
+48,279
| +101% | +$2.4M | ﹤0.01% | 1470 |
|
|
2016
Q2 | $2.29M | Sell |
47,586
-28,029
| -37% | -$1.35M | ﹤0.01% | 1992 |
|
|
2016
Q1 | $3.45M | Buy |
75,615
+67,647
| +849% | +$3.09M | ﹤0.01% | 1598 |
|
|
2015
Q4 | $429K | Sell |
7,968
-750
| -9% | -$40.4K | ﹤0.01% | 3270 |
|
|
2015
Q3 | $430K | Sell |
8,718
-39,840
| -82% | -$1.97M | ﹤0.01% | 3299 |
|
|
2015
Q2 | $2.83M | Sell |
48,558
-24,861
| -34% | -$1.45M | ﹤0.01% | 2055 |
|
|
2015
Q1 | $4.22M | Buy |
73,419
+37,050
| +102% | +$2.13M | ﹤0.01% | 1619 |
|
|
2014
Q4 | $1.84M | Buy |
36,369
+480
| +1% | +$24.2K | ﹤0.01% | 2293 |
|
|
2014
Q3 | $1.68M | Hold |
35,889
| – | – | ﹤0.01% | 2291 |
|
|
2014
Q2 | $1.62M | Buy |
35,889
+28,845
| +409% | +$1.3M | ﹤0.01% | 2522 |
|
|
2014
Q1 | $297K | Sell |
7,044
-360
| -5% | -$15.2K | ﹤0.01% | 3745 |
|
|
2013
Q4 | $291K | Buy |
7,404
+180
| +2% | +$7.08K | ﹤0.01% | 3650 |
|
|
2013
Q3 | $256K | Sell |
7,224
-120
| -2% | -$4.25K | ﹤0.01% | 3435 |
|
|
2013
Q2 | $244K | Buy |
+7,344
| New | +$244K | ﹤0.01% | 3362 |
|